相似文献
1
Severe hepatic failure related to nevirapine treatment.
Clin Infect Dis. 1999 Aug;29(2):455-6. doi: 10.1086/520242.
2
Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection.
Jpn J Infect Dis. 2000 Dec;53(6):244-5.
3
[Favorable new data for nevirapine. Antiretroviral effect confirmed--and also lipid profile].
MMW Fortschr Med. 2004 Apr 26;146 Spec No 1:58-60.
4
[Combined antiretroviral therapy with nevirapine of HIV-infected adults].
Ter Arkh. 2004;76(11):68-71.
5
Switch study of nevirapine.
AIDS Patient Care STDS. 2000 Dec;14(12):672.
6
[Reliable effectiveness for years with good long-term tolerance: 10 years nevirapine--a summary].
MMW Fortschr Med. 2008 Apr 28;150 Spec No 1:70.
7
DRESS (drug rash with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy.
Clin Infect Dis. 1998 Nov;27(5):1321-2.
8
[Reliability: nevirapine. Highly effective + favorable influence on lipid profile].
MMW Fortschr Med. 2005 Apr 25;147 Spec No 1:42-3.
9
A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load.
HIV Med. 2005 Sep;6(5):353-9. doi: 10.1111/j.1468-1293.2005.00320.x.
10
Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients.
AIDS. 2007 Jul 31;21(12):1561-8. doi: 10.1097/QAD.0b013e3282170a9d.
引用本文的文献
1
Acute hepatic failure and lactate acidosis associated with antiretroviral treatment for HIV.
Wien Klin Wochenschr. 2003 Feb 28;115(3-4):135-40. doi: 10.1007/BF03040295.
Zotero 插件